Human antibodies targeting cell surface antigens overexpressed by the hormone refractory metastatic prostate cancer cells: ICAM-1 is a tumor antigen that mediates prostate cancer cell invasion

Transition from hormone-sensitive to hormone-refractory metastatic tumor types poses a major challenge for prostate cancer treatment. Tumor antigens that are differentially expressed during this transition are likely to play important roles in imparting prostate cancer cells with the ability to grow...

Descripción completa

Detalles Bibliográficos
Autores principales: Conrad, Fraser, Zhu, Xiaodong, Zhang, Xin, Chalkley, Robert J., Burlingame, Alma L., Marks, James D., Liu, Bin
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2009
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2796542/
https://www.ncbi.nlm.nih.gov/pubmed/19219419
http://dx.doi.org/10.1007/s00109-009-0446-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2796542/
https://www.ncbi.nlm.nih.gov/pubmed/19219419
http://dx.doi.org/10.1007/s00109-009-0446-3

Ejemplares similares